Single-center, retrospective study on changes in pain-relieving therapy after bone metastasis detection by bone scintigraphy in prostate cancer patients

Whole-body bone scintigraphy (WB-BS) is used for detecting and monitoring metastatic spread of prostate cancer (PCa) to investigate pain episodes. To the impact a positive WB-BS on pain-relieving medicine prescription in PCa patients, single-center, retrospective cohort study with patients classified as metastases (BM) by was conducted. Demographic, clinical, ambulatory data were evaluated. Pain-relieving medicines categorized according WHO ‘Analgesic Ladder’. Regimens adopted before after compared. Differences considered significant at p<0.05. A total 180 diagnosed BM, 64.4% whom ≥65 years age. Thirty-three prescribed analgesics only WB-BS, mostly including NSAIDs weak opioids. changed prescriptions reduction adjuvants an increase strong In addition, 40% analgesic step 1 drugs 21.7% 2 other steps WB-BS. providing evidence that it could contribute clinical management painful patients.